Jobs Archive | PKD Clinical Studies

Showing 1 – 10 of 51 results

RSS Feed

Active

ADPKD Registry

Online

Browse Job

Active

Renal Oxygen Consumption, Insulin Sensitivity, and Daily Caloric Restriction in ADPKD (EXPLORE)

University of Colorado Anschutz Medical Campus, East 17th Place, Aurora, Adams County, Colorado, 80045, United States

Browse Job

Active

Well-Formulated Ketogenic Diet in Polycystic Kidney Disease

The Ohio State University

Browse Job

Active

Patient-Centered Insights on Treatment Adherence and Social Determinants of Health

United States

Browse Job

Active

Genetic Testing in Autosomal Dominant Polycystic Kidney Disease

San Francisco, California, United States

Browse Job

Active

Study and Management of Cystic Complications in Autosomal Dominant Polycystic Kidney Disease (COMPLIK)

France

Browse Job

Active

ZEUS – A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation (ZEUS)

Multiple Locations

Browse Job

Active

A Randomized, Placebo-controlled, Double-blind, Multi-center Phase 2/3 Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot (CAM2029) in Patients with Symptomatic Polycystic Liver Disease

Multiple Locations

Browse Job

Active

Feasibility of Study of Empagliflozin in Patients With ADPKD

Multiple locations

Browse Job

Active

PB to reduce increased urination related to tolvaptan therapy in patients with ADPKD

Jacksonville, Duval County, Florida, United States

Browse Job

ADPKD Registry

Renal Oxygen Consumption, Insulin Sensitivity, and Daily Caloric Restriction in ADPKD (EXPLORE)

Well-Formulated Ketogenic Diet in Polycystic Kidney Disease

Patient-Centered Insights on Treatment Adherence and Social Determinants of Health

Genetic Testing in Autosomal Dominant Polycystic Kidney Disease

Study and Management of Cystic Complications in Autosomal Dominant Polycystic Kidney Disease (COMPLIK)

ZEUS – A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation (ZEUS)

A Randomized, Placebo-controlled, Double-blind, Multi-center Phase 2/3 Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot (CAM2029) in Patients with Symptomatic Polycystic Liver Disease

Feasibility of Study of Empagliflozin in Patients With ADPKD

PB to reduce increased urination related to tolvaptan therapy in patients with ADPKD

Quick Links

For Candidates

For Employers

Featured Job

Reset Password

Quick Links

For Candidates

For Employers

Featured Job